IP Library Granted Patent US 9,689,868
Granted Patent B2
US 9,689,868 · App. 15/281,460 · Granted Jun 27, 2017

Protein labeling with cyanobenzothiazole conjugates

Inventors: Jessica Kelts (Flint, MI); Poncho Meisenheimer (San Luis Obispo, CA); John Shultz (Verona, WI)
Assignee: PROMEGA CORPORATION
G01N33/533C07D417/14C07D493/10C07D495/04C09B11/08C09B11/24C09B23/083
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,689,868
App. No.
15/281,460
Granted
Jun 27, 2017
Kind
B2
Abstract

The invention provides compounds and methods for site-specifically labeling proteins with cyanobenzothiazole derivatives of formula I. For example, the invention provides methods for labeling the N-terminus of a protein that terminates with a cysteine residue. The invention also provides methods for isolating an N-terminally labeled protein and methods for detecting an N-terminally labeled protein.

Claims (17)

1. A method for immobilizing a protein of interest, comprising:

a) contacting a sample comprising an N-terminal cysteine labeled protein of interest with a cyanobenzothiazole derivative of Formula I

wherein

Z is H, F, Cl, Br, I, CN, amino, alkylamino, dialkylamino, alkyl ester, carboxy, carboxylic acid salt, alkyl amide, phosphate, alkyl phosphonate, sulfate, alkyl sulfonate, nitro, or C 1 -C 10 alkyl optionally unsaturated and optionally substituted with amino, hydroxy, oxo (═O), nitro, thiol, or halo;

each R 1 is independently H, F, Cl, Br, I, CN, C 1 -C 6 alkyl, C 1 -C 6 alkoxy, or C 1 -C 6 alkylthio, wherein each alkyl, alkoxy, or alkylthio is optionally substituted with F, Cl, Br, I, amino, alkenyl, alkynyl, cycloalkyl, aryl, alkyl sulfonate, or CO 2 M wherein M is H, an organic cation, or an inorganic cation;

n is 0, 1, or 2;

Y is a linking group comprising C 1 -C 16 alkylene optionally substituted with one or more halo, oxo (═O), C r O 6 alkyl, or C 1 -C 6 alkoxy, and optionally interrupted with one or more N(R 1 ), O, S, or —NH—C(═O)— groups; and

X is a solid support;

and

b) immobilizing the protein of interest.

2. The method of claim 1 , wherein the protein of interest is purified.

3. The method of claim 1 , wherein the solid support is a particle, resin, bead, or surface.

4. The method of claim 1 , wherein the solid support comprises a silicate, polymer, sepharose, cellulose, alginate, polystyrene, a membrane, or glass.

5. The method of claim 1 , wherein the solid support is paramagnetic or magnetic.

6. The method of claim 1 , wherein the protein of interest maintains its functionality upon immobilization.

7. The method of claim 1 , wherein immobilization provides site-specific immobilization of the protein of interest.

8. The method of claim 7 , wherein the site-specific immobilization occurs at the N-terminal cysteine of the protein of interest.

Assignments (2)
SECURITY INTEREST Recorded Apr 3, 2019
From: PROMEGA CORPORATION; PROMEGA BIOSCIENCES, LLC; TERSO SOLUTIONS, INC.; ORION SEVEN, LLC; PROMEGA AVIATION LLC
To: JPMORGAN CHASE BANK, N.A., AS COLLATERAL AGENT
Reel/Frame 048790/0259 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 22, 2017
From: KELTS, JESSICA; MEISENHEIMER, PONCHO; SHULTZ, JOHN
To: PROMEGA CORPORATION
Reel/Frame 042452/0502 →
Continuity (3)
Continuation 12383832 · Mar 26, 2009
Provisional Application 61040073 · Mar 27, 2008
Related Publication 20170016888A1 · Jan 19, 2017